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The class III phosphatidylinositol 3-kinase (PI3K-III) complex and its phosphorylated lipid product
phosphatidylinositol 3-phosphate (PtdIns3P) control the three topologically related membrane-
involution processes autophagy, endocytosis, and cytokinesis. The activity of the catalytic unit of
PI3K-III complex, the Vacuolar sorting protein 34 (VPS34), depends on the membrane targeting
unit Vacuolar sorting protein 15 (VPS15), and the tumor suppressor protein Beclin 1. It is
established that the overall activity of VPS34 is positively regulated by Beclin 1, whose positive
inﬂuence is further controlled through the association with a set of Beclin1 interacting compo-
nents, which stimulate or inhibit VPS34. The interaction between Beclin 1 and Beclin 1-associated
components are controllable and is regulated by phosphorylation in a context-dependent manner.
Here, we focus on an emerging concept whereby the activity of the PI3K-III complex is controlled
by ubiquitination of Beclin 1 or Beclin 1-associated molecules. In summary, at least three different
ubiquitin ligases can affect the positive regulatory function of Beclin 1 towards VPS34, suggesting
that ubiquitination is an important and physiologically relevant event in tuning the tumor
suppressor function of Beclin 1.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Phosphatidylinositol 3-kinases and tumor suppression
Phosphoinositides are phosphorylated derivatives of phosphati-
dylinositol (PtdIns) that control cellular processes through recruit-
ment of cytosolic proteins with a variety of lipid interaction motifs
to speciﬁc membranes. In mammals three classes of phosphatidyl-
inositol 3-kinases (PI3K) exist, which have in common that they
phosphorylate the three-hydoxyl group of the inositol ring, but dif-
fer in their substrate speciﬁcity and the resulting catalytic product
[1]. These three classes, called PI3K class I, II and III, collectively ini-
tiate lipid signaling cascades to initiate cellular responses such as
growth, proliferation, survival, motility, intracellular trafﬁcking,
metabolism and homeostasis [1,2]. The class I PI3K (PI3K-I) is
activated downstream of receptor tyrosine kinases (RTKs) and
G-protein coupled receptors (GPCR) and preferably generatesal Societies. Published by Elsevier
edicine, Faculty of Medicine,
y. Fax: +47 22781845 (H.
t für Physiologische Chemie,
D-44780 Bochum, Germany.
o (H. Abrahamsen), harald.phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3 or PIP3) from
phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2 or PIP2) in the
plasma membrane. The initial signaling events downstream of the
activated PI3K-I is most often mediated by proteins containing
Pleckstrin homology domains (PH domains). PH-domain containing
proteins are known to interact with PI(3,4,5)P3 and compartmental-
ize signaling by recruiting other signaling molecules in the proxim-
ity to the activated receptor. The PI3K-I is the best studied of the
three lipid kinases as it activates one of the major survival and
proliferative pathways controlled by the PH domain-containing
Ser/Thr kinase Akt. The class I PI3K pathway is associated with
tumorigenesis as it is often found to be upregulated during cancer
development due to hyperactivated RTKs, loss of function muta-
tions in the gene encoding phosphatase and tensin homolog (PTEN)
or presence of oncogenic forms of the regulatory small GTPase RAS.
The class II PI3K can generate phosphatidylinositol 3-phosphate
(PtdIns3P) and phosphatidylinositol 3,4-bisphosphate (PtdIns
(3,4)P2) from phosphatidylinositol and PtdIns4P, respectively.
How the kinases in this family are regulated and which cellular
processes they control is currently unclear [2].
The focus of this review is the class III PI3K (PI3K-III) or Vacuo-
lar sorting protein 34 (VPS34), the primordial member of the PI3Ks,B.V. Open access under CC BY-NC-ND license. 
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PtdIns3P [3–5]. The PtdIns3P production by VPS34 mainly occurs
on intracellular membranes and PtdIns3P is best known to localize
to endosomes and specialized domains of multivesicular bodies
[6]. However, PtdIns3P has also been detected at phagosomes
[7,8] peroxisomes [9] and pre-autophagosomal structures that
are dynamically connected to the endoplasmic reticulum [10–
12]. Once generated at intracellular membranes, PtdIns3P func-
tions as a signaling molecule that mediates the recruitment of
PtdIns3P interacting proteins (PtdIns3P effector proteins) involved
in sorting and proteolytic events such as growth factor receptor
down-regulation, endocytic signal transduction and autophagy
[13–15]. Additionally, VPS34 is important for regulation of cytoki-
nesis, a membrane modulatory event that leads to the physical and
equal separation of the cytosol between two daughter cells after
the completion of mitosis [16,17]. Thus, in theory, VPS34 might
perform tumor suppressor activities by terminating growth factor
receptor signaling [18], by the engulfment of damaged and old
organelles in autophagosomes, or through preventing bi-nucle-
ation and genome instability through ensuring correct cytokinesis
[19–22,29]. The PtdIns3P effector proteins normally either contain
a Fab1p, YOTB, Vac1p, and EEA1 domain (FYVE domain) or a Phox
homology domain (PX domain) that are responsible for mediating
their localization to a particular membrane. Interestingly though,
in order to accomplish full activity in vivo VPS34 has to team up
with a set of proteins that assist both in localization and activation.
The composition of the entire PtdIns3P generating catalytic unit,
often referred to as the PI3K-III complex, changes according to
the speciﬁc cellular event mediated by VPS34 and its effector pro-
teins [14,23] (Fig. 1B). In this review, we will summarize and dis-
cuss recent publications that provide evidence that post-
translational modiﬁcations such as phosphorylation and ubiquiti-
nation are involved in controlling PI3K-III activity by modulating
the composition of the complex.
2. Modulation of PI3K-III activity through a tunable assembly of
Beclin 1-associated proteins
The core components of the PI3K-III complex, the catalytic unit
VPS34, its myristoylated membrane targeting unit VPS15/p150
[24] and the positive modulatory unit Beclin 1 (Atg6/Vps30) [25],
are all required for the correct compartmentalized and timely acti-
vation of the PI3K-III complex during membrane-associated events
(Fig. 1A). Furthermore, although Beclin 1 positively modulates the
VPS34 kinase activity, its ability to do so depends on a network of
Beclin 1 interacting proteins [14,23,26]. Some VPS34 and Beclin 1-
associated proteins are also involved in mediating distinct mem-
brane-localization and signal compartmentalization in a temporal
manner (Fig. 1A).
Positive regulatory proteins that interact directly with Beclin 1
are UV radiation resistance-associated gene (UVRAG) [27], activat-
ing molecule in Beclin 1-regulated autophagy (AMBRA1) [28], and
Autophagy-related protein 14-like protein (ATG14L) [12,29–32].
UVRAG and ATG14L are mutually exclusive partners of Beclin 1
and have been shown to participate in the activation of two differ-
ent VPS34 containing complexes that regulate different steps in the
autophagic process [31] (Fig. 1A). AMBRA1 only associates with the
ATG14L positive PI3K-III complex and thus seems to play a role in
autophagy (Fig. 1A) [28]. Although the actual contribution of UV-
RAG in autophagy is under debate [33,34] (see also discussion in
[14]) UVRAG has an undisputed role in endosomal sorting [27]
and cytokinesis [17] as well as apoptosis and development in Dro-
sophila melanogaster [34].
Through UVRAG, Beclin 1 also associates indirectly with the po-
sitive regulator Bax-interacting factor 1 (BIF-1) or the inhibitorypartner run domain Beclin 1-interacting and cysteine-rich contain-
ing protein (RUBICON), which are positive or negative regulators of
autophagy, respectively (Fig. 1A) [12,29,35], 2009 #45}.
The proto-oncogene and anti-apoptotic protein B-cell lym-
phoma 2 (BCL-2) is the only inhibitory protein known to associate
directly with Beclin 1 [36,37]. The interaction between Beclin 1 and
BCL-2 is mediated by the BH3 domain of Beclin 1 and the linker be-
tween the BH3 and BH4 domains in BCL-2 [38] (Fig. 1B). It has been
proposed that BCL-2 prevents Beclin 1 oligomerization and VPS34
association and therefore hampers assembly of an active VPS34
complex [39–42]. Consequently, it has been proposed that oligo-
merized Beclin 1 can function as a platform onto which the other
interacting proteins rapidly can assemble to promote VPS34 activ-
ity [41,42], making BCL-2 a critical regulatory component of the
PI3K-III complex.
3. Regulation of PI3K-III activity by VPS34 phosphorylation
It is well established that cyclin-dependent kinases (CDKs) are
critical for cell cycle regulation [43]. Recently, it was also shown
that CDKs are involved in controlling PtdIns3P production in a cell
cycle dependent manner [44]. Furuya and co-workers showed that
the kinase activity of VPS34 is affected through a temporal cyclin
dependent kinase 1 (CDK1)-mediated phosphorylation of VPS34
at Thr159 in its C2 domain that disrupts its interaction with Beclin
1 [44] (Fig. 1B). The CDK1-mediated disruption of the complex oc-
curs between metaphase and anaphase and results in VPS34 inhi-
bition that is associated with an abrupt decrease in the PtdIns3P
production at the entry into mitosis (Fig. 2A). The PI3K-III complex
re-assembles at the onset of anaphase and restores PtdIns3P pro-
duction. It is not yet clear why PtdIns3P production is reduced dur-
ing mitosis and if this is related to mitotic progression in any way,
but it was suggested by the authors that it is important that
autophagy must be turned off at this point in the cell cycle. How-
ever, since PtdIns3P also plays a role in endocytic events and cyto-
kinesis, other explanations as to why a temporal loss of VPS34
activity in mitosis is of importance might be revealed in the future.
A targeted disruption of the process-speciﬁc PI3K-III complexes by
knock-down of components such as ATG14L, AMBRA1, BIF-1 or
RUBICON might further clarify which complex is involved in the
PtdIns3P production as the cells enter mitosis and which PI3K-III
complex is responsible for the PtdIns3P production again after
complex reassembly in anaphase.
Furuya et al. also showed that CDK5 negatively regulates PI3K-
III activity by phosphorylating VPS34 at Thr668 [44] (Fig. 1B). The
CDK5-mediated phosphorylation clearly abolishes the lipid kinase
activity of VPS34 but a molecular explanation as to how phosphor-
ylation at Thr668 inhibits VPS34 was not discussed [44]. A second
recent paper describes that the Ser/Thr protein kinase D (PKD)
interacts with the PI3K-III complex and phosphorylates VPS34 at
Thr677 (Fig. 1B). The PKD-mediated phosphorylation at Thr677
activates VPS34 and increases autophagy upon oxidative stress
[45] (Fig. 2A). Interestingly, Thr668 (CDK5 site) and Thr677 (DAPK
site) have in common that they are localized in the catalytic do-
main of VPS34 and might be structurally important residues whose
phosphorylation could affect catalytic activity by altering structur-
ally important elements in the kinase domain (for structural details
see VPS34 structure in [46]).
4. The interaction between Beclin 1 and BCL-2 is modulated by
phosphorylation and ubiquitination
The idea that VPS34 activity can be modulated by tuning the
amount of BCL-2 bound to Beclin 1 has been gaining support
through several recent publications: it has been reported that
Fig. 1. PI3K-III complexes: composition, cellular function and structure. (A) The core components of the PI3K-III complex, VPS34, VPS15, and Beclin 1 are essential for the
catalytic activity of VPS34 and are important for all of the PtdIns3P producing complexes in a cell (core complex). It is the Beclin 1-interacting molecules that typically dictate
where and when the PI3K-III complex can be active. ATG14L interacts with Beclin 1 and is an essential component of the PI3K-III complex in autophagy as it targets the
complex to the endoplasmatic reticulum (ER). Specialized regions within the ER have been suggested to serve as the site where the autophagosome formation begins and
PtdIns3P is important for this process. AMBRA1 only associates with the ATG14L positive PI3K-III complex and functions in the early phases of autophagy (ATG14L complex).
ATG14L and UVRAG bind Beclin 1 in a mutually exclusive manner and distinguish between two functionally different PI3K-III complexes (ATG14L complex and UVRAG
complexes), which are involved in two different steps of the autophagic process (formation and maturation). The activity of the UVRAG containing complex is stimulated by
the interaction with BIF1 to promote autophagosome maturation, endocytosis and cytokinesis (activating UVRAG complex). Rubicon binds a subpopulation of UVRAG
complexes and inhibits the maturation of autophagosomes (inhibitory UVRAG complex). (B) Schematic drawing of the domain structure of VPS15, VPS34, Beclin 1, and BCL-2
(not proportional). The blue lines between each linear protein structure indicate which regions are used for mediating their interaction with each other. The green circle
indicates the ubiquitinated residue and the residue being modiﬁed is indicated above it. The E3 ligase regulating the ubiquitination is also indicated. Likewise, gray circles are
phosphorylated residues. Abbreviations used in this ﬁgure for the domains include CCD (coil-coiled domain), ECD (evolutionary conserved domain), TM (transmembrane
domain), and HEAT (Huntington, Elongation Factor 3, PR65/A, TOR), BH (Bcl-2 Homology).
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tion at the contact interface between the two molecules controls
VPS34 activity.
The covalent attachment of ubiquitin to a protein is catalyzed in
a three-enzyme cascade comprising E1 (ubiquitin activating en-
zyme), E2 (ubiquitin conjugating enzyme) and E3 (ubiquitin pro-
tein isopeptide ligase) enzymes. The substrate speciﬁcity of this
reaction is deﬁned by the E3 ubiquitin ligase, which either directly
or indirectly interacts with the target. Modiﬁcation of a protein
with ubiquitin typically changes its destiny, by targeting it for pro-
teasomal or lysosomal degradation [47,48]. Ubiquitination can also
have a non-proteolytic inﬂuence by altering localization or binding
partners [49,50].
The ﬁrst study introducing the idea that the interaction between
BCL-2 and Beclin 1 can be modulated showed that starvation-in-
duced C-Jun N-terminal Kinase 1 (JNK1)-mediated phosphorylation
of BCL-2 at Thr69, Ser70, and Ser87 leads to its dissociation fromBeclin 1 (Fig. 2A). The dissociation of BCL-2 from Beclin 1 is accom-
panied by an increase in autophagy [36,51]. BCL-2 phosphorylation,
as well as BCL-2 dissociation fromBeclin 1 upon starvation, was lost
in JNK1 knock-outMEFs, indeed suggesting that JNK1 is responsible
for this effect. The JNK1 phosphorylation sites are localized within
the non-structured loop of BCL-2, which links its BH3 and BH4 do-
mains and mediates the interaction with Beclin 1 (Fig. 1B). Phos-
phorylation of the BCL-2 linker region has also previously been
suggested to affect the ability of BCL-2 to associate with the BH3-
containing protein FK-506 binding protein 38 (FKBP38) [52].
Dissociation of BCL-2 family members from Beclin 1 followed
by an increase in autophagy, has also been found after direct phos-
phorylation the Beclin 1 BH3 domain (Thr119) by DAPK [53]
(Fig. 1B). The Beclin 1 BH3 domain is responsible for binding
BCL-2, suggesting that disruption of the interaction surface
between BCL-2 and Beclin 1 is sufﬁcient to reduce the contact be-
tween these two molecules. Taken together, the available data
Fig. 2. Modulation of PI3K-III activity through phosphorylation and ubiquitination. (A) Regulation of PI3K-III activity by phosphorylation. BCL-2 is a Beclin 1 interacting
molecule, which down-regulates the activity of the PI3K-III complex through its association with Beclin 1. The inhibitory function of BCL-2 can be disrupted by either DAPK-
mediated phosphorylation of Beclin 1 at Thr677 or by JNK mediated phosphorylation of BCL-2 at Ser70 (and probably the surrounding residues Thr69 and Ser87). CDK1-
mediated phosphorylation of VPS34 at Thr159 disrupts the interaction between Beclin 1 and VPS34 and inhibits VPS34 activity completely. This CDK1-mediated disruptive
phosphorylation occurs only when CDK1 is active in mitosis. The interaction between VPS34 and Beclin 1 re-appears again as the cells have progressed to anaphase. (B)
Modulation of PI3K-III activity by ubiquitination. Three different ubiquitin ligases, NEDD4, TRAF6 and Parkin1 can modulate PI3K-III activity. NEDD4 ubiquitinates Beclin 1
through a Lys11-linked polyubiquitin chain (K11) and preferably do so when Beclin 1 is not bound to VPS34, suggesting that NEDD4 function as part of a quality control
mechanism for Beclin 1. TRAF6 releases the inhibitory interaction between Beclin 1 and BCL-2 by adding a Lys63-linked polyubiquitin chain (K63) to the BH3 domain in Beclin
1 and allows PI3K-III activity. The inhibitory function of BCL-2 is enhanced when it is monoubiquitinated and stabilized by the E3 ligase Parkin 1. The deubiquitinating
enzymes USP10 and USP13 are deubiquitinating enzymes that associate with the PI3K-III complex. When their peptidase activity is inhibited by Spautin-1, Beclin 1 becomes
ubiquitinated and will lead to the destabilization and degradation of the entire PI3K-III complex.
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by Beclin 1 phosphorylation and one by VPS34 phosphorylation,
both of which activates VPS34 kinase activity [45,53] (Fig. 2A). It
is worth noting that the DAPK promoter has been found hyperme-
thylated in prostate carcinomas [54] and it is not unlikely that loss
of DAPK expression in cancers associates with reduced PtdIns3P-
regulated processes such as autophagy. It will be interesting to
see if DAPK also plays a role in regulating PthIns3P production out-
side autophagy and how this affects tumorigenesis.
A third pathway that leads to dissociation of BCL-2 from Beclin 1
involves the non-proteolytic Lys63-linked ubiquitination of Beclin
1 at Lys117 within its BH3 domain [55] (Fig. 1B). Disruption of
the association between BCL-2 and Beclin 1 by ubiquitination isshown to bemediated by the E3-ligase tumor necrosis factor recep-
tor (TNFR)–associated factor6 (TRAF6) (Fig. 2B), which Beclin 1
interacts with in response to lipopolysaccharide (LPS) and amino-
acid starvation in macrophages. By rendering Beclin 1 insensitive
to TRAF6-mediated ubiquitination (Lys117 to Arg mutation) or by
overexpression of the deubiquitinating enzyme A20, the LPS-med-
iated autophagy was greatly reduced, indicating that Lys63-linked
ubiquitination of Beclin 1 and disruption of the interaction with
BCL-2 is necessary for macrophages in order to clear pathogens
by autophagy upon pathogen encounter. It is tempting to speculate
that phosphorylation of Beclin 1 at Thr119 (DAPK site) might have a
priming function for Beclin 1 ubiquitination at Lys117 as certain E3
ligases have certain phosphorylation requirements. It will be
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tion of Beclin 1 can be demonstrated in the future.
The ubiquitin ligase Parkin, which is frequently found to be mu-
tated in the neurodegenerative Parkinson’s disease [56], is involved
in a fourth possibility to regulate the association of Beclin 1 with
BCL-2 (Fig. 2B). It has been described that Parkin stabilizes BCL-2
by mediating its monoubiquitination [57]. It is not known how
monoubiquitination contributes to the stability of BCL-2. However,
because monoubiquitination often induces conformational
changes, results in altered intracellular localization, or leads to a
change in binding partners [58], it is likely that monoubiquitinated
BCL-2 is rendered insensitive to yet unknown destabilizing forces.
For example, monoubiquitination of BCL-2 could prevent it from
interacting with ubiquitin ligases that normally would target BCL-
2 for proteasomal degradation. Clearly, monoubiquitinated BCL-2
has a longer half-life compared to non-ubiquitinated BCL-2, sug-
gesting that upon monoubiquitination more BCL-2 becomes avail-
able to interact with Beclin 1 so that PI3K-III activity is repressed
[57]. These ﬁndings are interesting but hard to fully reconcile with
a series of publications pointing towards a positive role for Parkin in
mitochondria-speciﬁc autophagy or mitophagy [59,60] urging a
deeper understanding of the role of Parkin in VPS34 regulation.
Although the interaction between BCL-2 and Beclin 1 can be
regulated both by ubiquitination and by phosphorylation in vari-
ous ways, it is not clear at this point if these events are linked. It
has also not yet been reported whether BCL-2 affects growth factor
receptor sorting or cytokinesis, opening up for several new arenas
for future investigation.
5. Ubiquitination and proteasomal degradation of PI3K-III
associated proteins
As discussed above, different cellular clues determine VPS34
activity by controlling the level of BCL-2 interacting with Beclin
1. Interestingly, other ubiquitin-dependent pathways that alter
VPS34 activity have been described. First, Beclin 1 can be polyubiq-
uitinated through Lys11-linked ubiquitin chains by the E3 ligase
neural precursor cell expressed developmentally down-regulated
protein 4 (NEDD4) [61] (Fig. 2B). NEDD4-mediated ubiquitination
of Beclin 1 affects the steady-state concentration of Beclin 1 in
the cell. Additionally, when VPS34 expression is reduced by siRNA
the ubiquitination and degradation of Beclin 1 by NEDD4 is en-
hanced [61], suggesting that NEDD4 could be part of a cellular
quality control mechanism that targets free Beclin 1. One known
example of temporally and controlled dissociation of Beclin 1 from
VPS34 occurs upon CDK1-mediated phosphorylation of VPS34 at
Thr159 [44]. When cells enter mitosis and CDK1 activity is high,
VPS34 becomes phosphorylated by CDK1 and its association with
Beclin 1 is lost, resulting in a pool of free Beclin 1. Could this free
Beclin 1 be a target for NEDD4?
Disruption of the contact between VPS34 and Beclin 1 in mitosis
is associated with a sudden drop in the level of PtdIns3P positive
vesicles and reduced autophagy. PtdIns3P production reappears
again when VPS34 and Beclin 1 re-associate in anaphase. How
deubiquitinating enzymes and phosphatases participate in regulat-
ing this dissociation and re-association during mitosis is not
known and opens up for additional interesting aspects to study.
It is worth noting that by knocking down either Beclin 1 or
VPS15, the stability of several components in the PI3K-III complex
is affected [17,31]. Why and how this occurs and what type of
ubiquitination linkage the various PI3K-III components are modi-
ﬁed with under such conditions has not been established to date.
Although NEDD4-mediated polyubiquitination degrades free
Beclin 1, it was recently suggested that another mechanism comes
into play when Beclin 1 bound to VPS34 is targeted by ubiquitina-
tion [62] (Fig. 2B). Liu et al. screened for chemical inhibitors thatcan target autophagy and found that the deubiquitinating enzymes
(DUBs) ubiquitin carboxyl-terminal hydrolase 10 (USP10) and
USP13 are responsible for balancing the stability of the entire
PI3K-III complex by controlling the ubiquitination of Beclin 1
[62] (Fig. 2B). The new chemical autophagy inhibitor identiﬁed in
their screen, called speciﬁc and potent autophagy inhibitor-1
(Spautin-1), directly and potently inhibits the peptidase activity
of UPS10 and UPS13, which interacts with Beclin 1. Spautin-1
treatment resulted in increased Beclin 1 ubiquitination and degra-
dation followed by ubiquitination and destabilization of VPS34,
VPS15, and ATG14L and reduced overall PtdIns3P production
[62]. Based on the PtdIns3P loss induced by Spautin-1 it is unlikely
that Spautin-1 only affects autophagy. A general loss of PtdIns3P
should also affect endocytosis and cytokinesis but this was not
investigated. Therefore, characterization of Spautin-1 and its role
as a general PI3K-III inhibitor will need further investigation.
A different interesting observation made in the Spautin-1 paper
is that knock-down of Beclin 1 and VPS34 also affects the stability
of USP10 and USP13, suggesting feedback in the regulatory path.
USP13 might also regulate the ubiquitination of USP10, indicating
the existence of an intricate network of ubiquitination and deubiq-
uitination controlling VPS34 activity. The ubiquitin ligase(s) that
mediates the ubiquitination of Beclin 1 after Spautin-1 treatment
has not been identiﬁed yet. However, it is reasonable to think that
by taking advantage of Spautin-1, ubiquitin ligases whose knock-
down rescues the Spautin-1-induced degradation of Beclin 1 can
be identiﬁed and characterized in cellular processes such as
autophagy, endocytosis and cytokinesis.
In an independent DUB interactome study, immunoprecipita-
tion using Unc-51-like kinase 1 (ULK1) as the bait resulted in
USP10 co-precipitation [63]. ULK1 is the described mammalian
homolog of ATG1, and is a protein kinase involved in the induction
of autophagy. It has been shown that ULK1 assembles together
with the VPS34 complex onto the Exocyst complex subunit,
EXO84, after its starvation-induced activation by the small GTPase
RALB [64,65]. The link between RALB/EXO84/ULK1, USP10 and
VPS34/Beclin 1 suggests the presence of an interesting regulatory
network whose triggers and breaks that certainly will have to be
explored in the coming years.
The molecular chaperone Heat shock protein 90 (HSP90) might
also be involved in controlling Beclin 1 stability and thus VPS34
activity. A recent publication describes an interaction between Be-
clin 1 and HSP90 in monocytes [66]. In these cells, Geldanamycin-
mediated inhibition of HSP90 induced the formation of K48-linked
ubiquitin chains on Beclin 1 and effectively reduced Beclin 1 levels
in a proteasomal dependant manner. HSP90 typically assists in
protein stabilization by aiding protein folding. It will be interesting
to see if HSP90 plays a general role in controlling Beclin 1 stability
or whether this is a regulatory event speciﬁcally developed in
phagocytic cells.
In addition to the abovementioned studies that clearly link
ubiquitination to the regulation of Beclin 1, there are some addi-
tional ubiquitin-related reports that could be relevant to consider
when studying the PI3K-III complex. For instance, AMBRA1 has
been identiﬁed as a substrate for cullin-related ligase (CRL) com-
plexes [67,68] and as a binding partner of the CUL4–DDB1–DDA1
CRL complex [69]. The AMBRA1-associated CRL has also been
found to be part of the Microtubule-associated protein light chain
3 (LC3)-interaction network [70]. Thus, the link to the CRL family
could possibly be used as a tool to study the PI3K-III complex in
autophagy.
It is also worth noting that several sites in VPS15 were found to
be modiﬁed by ubiquitin in a study characterizing the ubiquitin-
modiﬁed proteome (ubiquitinome) [71]. This is very interesting,
since regulation of VPS15 is still an unexplored area. Additionally,
the isolated eight-bladed b-propeller interaction domain (WD40)
H. Abrahamsen et al. / FEBS Letters 586 (2012) 1584–1591 1589of VPS15 can bind recombinant ubiquitin [72], indicating that the
VPS15 does not only interact with VPS34 and ATG14L but may also
function as ubiquitin-binding module in vivo.6. Different layers of complexity: additional targets for NEDD4,
TRAF6, and Parkin ubiquitin ligases
The recent ﬁnding that VPS34-associated proteins are direct tar-
gets for ubiquitin ligases leads to the model of an ubiquitin-depen-
dent regulation of PI3K-III activity. However, it is interesting to
note that the ubiquitin ligases such as NEDD4, TRAF6 and Parkin
also have additional roles at least in autophagy by targeting pro-
teins outside the PI3K-III complex interactome. For example,
TRAF6 also catalyzes the K63-linked polyubiquitination of the ki-
nase, Transforming growth factor b-activated kinase 1 (TAK1),
which can phosphorylate and activate JNK1 [73,74], a kinase
known to modify VPS34 activity through phosphorylation of BCL-
2 (Fig. 1B) [51]. Thus, TRAF6 can activate VPS34 by interfering with
the amount of BCL-2 bound to Beclin 1, either by ubiquitination of
the BCL-2 binding motif in Beclin 1 or by phosphorylating the re-
gion in BCL-2 required for the interaction with Beclin 1 [51,55].
However, because the Beclin 1 ubiquitination occurs in response
to inﬂammatory signals and the BCL-2 phosphorylation has been
investigated for starvation-dependent autophagy, it will be impor-
tant to elucidate, if these two different TRAF6-dependent pathways
can act simultaneously or in a stimulus dependent manner.
Although the physiological relevance of the quality control
pathway mediated by NEDD4-induced Lys11-linked ubiquitination
of Beclin 1 has not been addressed in detail yet, it is worth noting
that NEDD4 was found to be part of the LC3-interaction map of ba-
sal autophagy [70]. RNAi analysis revealed that the depletion of
NEDD4 leads to an increase of LC3-II (membrane bound form) stea-
dy-state levels upon inhibition of the vacuolar type H(+)-ATPase
using Baﬁlomycin A1 treatment, indicating that NEDD4 generally
functions to down-regulate autophagy [70].
Several reports additionally suggest NEDD4 as a ubiquitin ligase
acting on the lipid phosphatase PTEN, which is responsible for the
conversion of PI(3,4,5)P3 into PI(4,5)P2 [75]. PTEN terminates the
major proliferative and growth mediating pathways controlled
by Akt and the down-streammammalian target of rapamycin com-
plex 1 (mTORC1) to relieve the concomitant mTORC1-mediated
suppression of autophagy [2,76,77]. It has indeed been suggested
that PTEN regulates autophagy by quenching the Akt signal [78].
The counteracting force in this process is NEDD4, which tags PTEN
for proteasomal degradation by polyubiquitation [79]. Altogether,
the published data point to an inhibitory role of NEDD4 in autoph-
agy although this must be ﬁrmly established experimentally.
While the available data suggest that TRAF6 might act as a posi-
tive regulator and NEDD4 as negative regulator of autophagy, the
situation for the ubiquitin ligase Parkin is thought to be context
dependent. As already mentioned, Parkin has been shown to
directly monoubiquitinate BCL-2 [57], which results in the stabi-
lization of BCL-2 and a stronger interaction with Beclin 1 (Fig. 2).
Interestingly enough, this inhibitory effect on general autophagy
seems to be restricted to the cytosolic pool of Parkin and is thought
to be relevant under normal conditions as well as after starvation.
However, in case of mitochondrial damage, Parkin is recruited to
depolarized mitochondria by PTEN-induced putative kinase 1
(PINK1) and is important for the induction of mitochondria-speciﬁc
autophagy or mitophagy [60]. At the damaged mitochindria, Parkin
mediates the recruitment of AMBRA1 and thereby facilitates the
localized induction of PI3K-III activity there [80]. Parkin also ubiq-
uitinates several mitochondrial membrane proteins such asMitofu-
sin 1 and 2 [81] and it is believed that this ubiquitination function
as an attractant for ubiquitin-binding autophagy-receptors likesequestosome 1 (SQSTM1 or p62) and histone deacetylase 6
(HDAC6) [60,82]. These receptors bind the ubiquitin of themodiﬁed
targets concomitantly with the LC3-II molecules on the autophago-
some and thereby mediate the link between the damaged organelle
and the autophagic machinery [83].
Eventhough cytosolic Parkin stabilizes BCL-2 and thereby inhib-
its PI3K-III function [57], Parkin-mediated mitophagy is strictly
depending on PI3K-III complex activity because it can be blocked
by the PI3K inhibitor 3-methyladenine [59]. At present, it is not
easy to explain themechanism underlying the counteracting effects
of Parkin on these two PI3K-III mediated autophagic pathways.
7. Concluding remarks
Several members of the PI3K-III complex have been described to
function as tumor suppressors. Their tumor suppressor role may be
directly connected to the essential function of PtdIns3P signaling in
autophagy, endocytosis and cytokinesis because all three processes
can protect normal cells against transformation. Since the PI3K-III
complex is central to control PtdIns3P levels in all these cellular
processes it is natural that multiple layers of regulation govern
the activity of this lipid kinase complex. Especially the multivalent
adaptor protein Beclin 1 is known to be regulated at the transcrip-
tional level, via protein–protein interactions, and by post-transla-
tional modiﬁcation such as phosphorylation. In recent years,
Beclin 1 and Beclin 1-associated proteins have also emerged as no-
vel ubiquitin targets and present new ways to modulate VPS34
activity. Importantly, the ability of Beclin 1 to modulate VPS34
activity impinges on the three ubiquitin ligases TRAF6, NEDD4,
and Parkin, and three protein kinases JNK1, DAPK, and CDK1 illus-
trating the complex network utilized to ﬁne-tune VPS34 activity.
Unraveling how these functionalities intersect or selectively regu-
late the three PI3K-III complexes in endosomal, autophagosomal,
and cytokinetic pathways will not only provide fundamental mech-
anistic insight into these processes, but will untwine the tumor
suppression functions of PI3K-III and its catalytic product PtdIns3P.
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